STOCK TITAN

Adia Med (OTC: ADIA) keeps ticker as name change takes effect

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Adia Nutrition, Inc. reports a corporate name change to Adia Med, Inc. The company filed a Certificate of Amendment in Nevada on June 2, 2026, changing its legal name and updating its Amended and Restated Articles of Incorporation, with no other changes to articles or bylaws.

Regulatory approval of the name change from FINRA was received on July 10, 2026. Common stock continues to trade on the OTC Markets Venture Market under the ticker “ADIA”, and existing stock certificates remain valid and do not need to be exchanged. Future reports will use the new corporate name Adia Med, Inc.

Positive

  • None.

Negative

  • None.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Par value per share $0.001 per share Common A Stock registered under Section 12(g) of the Exchange Act
Name change effective date June 2, 2026 Date Certificate of Amendment and amended Articles filed in Nevada
FINRA approval date July 10, 2026 Date FINRA granted final approval of the corporate name change
CEO signature date August 17, 2026 Date the report was signed by the Chief Executive Officer
CFO signature date August 17, 2026 Date the report was signed by the Chief Financial Officer
Telephone number (321) 231-2843 Registrant’s telephone number for the principal executive offices
Certificate of Amendment regulatory
"filed with the Secretary of State of the State of Nevada a Certificate of Amendment"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
Amended and Restated Articles of Incorporation regulatory
"filed a Certificate of Amendment for the Company’s Amended and Restated Articles of Incorporation"
A company's amended and restated articles of incorporation are an updated, single-version legal document that replaces its original founding papers to reflect changes in the company’s basic rules—like its capital structure, classes of stock, voting rights, or board arrangements. Investors care because these updates can change who controls the company, how dividends or profits are shared, or whether existing shares are diluted; think of it as an updated blueprint that can alter ownership and value.
FINRA regulatory
"submitted all required documentation to FINRA and its transfer agent"
FINRA is the U.S. self‑regulatory organization that oversees brokerage firms and individual brokers, setting and enforcing rules to protect investors and keep markets orderly. Think of it as a referee and rulebook keeper for the broker industry: it licenses brokers, monitors their behavior, enforces standards, and runs complaint and arbitration systems, so investors can check records and have a path to resolve disputes.
OTC Markets Venture Markets market
"common stock will continue to trade on the OTC Markets Venture Markets"
iXBRL technical
"Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101)"
iXBRL is a digital filing format that embeds standardized machine-readable financial data inside the human-readable financial reports companies publish, like putting a spreadsheet under the printed pages. For investors, it makes it much quicker and more reliable to extract, compare and analyze financial numbers across companies and periods, reducing manual data entry errors and helping automated tools and analysts spot trends or inconsistencies faster.

FAQ

What corporate change did ADIA announce in this Form 8-K?

ADIA announced that it changed its corporate name from Adia Nutrition, Inc. to Adia Med, Inc.. The change was implemented through a Certificate of Amendment filed in Nevada and reflected in the Amended and Restated Articles of Incorporation.

When did the ADIA name change to Adia Med, Inc. become effective?

The name change became effective on June 2, 2026, when the Certificate of Amendment and amended Articles were filed in Nevada. FINRA granted final approval related to the name change on July 10, 2026, completing the regulatory process.

Will ADIA’s ticker symbol change after the name change to Adia Med, Inc.?

No, the company states that its common stock will continue to trade on the OTC Markets Venture Market under the ticker symbol “ADIA”. Only the corporate name changes to Adia Med, Inc.; the trading symbol remains the same.

Are existing ADIA stock certificates affected by the name change?

Existing ADIA stock certificates are not affected by the name change. The company states that outstanding certificates remain valid and do not need to be exchanged, so shareholders can continue to hold their current certificates.

Were there any other changes to ADIA’s articles of incorporation or bylaws?

No. The company states that the only changes were to update the corporate name to Adia Med, Inc. in its Amended and Restated Articles of Incorporation. It specifically notes that no other changes were made to the articles or bylaws.

Will future SEC reports for ADIA use the new name Adia Med, Inc.?

Yes. The company indicates that all future reports will be filed under the new corporate name “Adia Med, Inc.”. Despite the name change, the shares will still trade on the OTC Markets Venture Market under the ticker ADIA.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false --12-31 0001160420 0001160420 2026-07-10 2026-07-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 10, 2026

 

Commission File Number: 000-33265

 

ADIA NUTRITION, INC.
(Exact name of registrant as specified in its charter)

 

nevada 35-2829671
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)

 

4421 Gabriella Ln. Suite 205, Winter Park, FL, 32789

(Address of principal executive offices)(Zip Code)

 

(321) 231-2843

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(g) of the Act: Common A Stock, par value $0.001 per share

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company           

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws

 

On June 2, 2026, we filed with the Secretary of State of the State of Nevada a Certificate of Amendment to amend our corporate name from Adia Nutrition, Inc. to Adia Med, Inc. A copy of the Certificate of Amendment of is attached as Exhibit 3.1 hereto and incorporated by reference.

 

In connection with our name change, our board of directors also filed a Certificate of Amendment for the Company’s Amended and Restated Articles of Incorporation to change our corporate name within our Articles of Incorporation to reflect the corporate name Adia Med, Inc., also effective on June 2, 2026. No other changes were made to our articles of incorporation or by-laws. A copy of the Amended and Restated Articles of Incorporation reflecting this amendment is attached as Exhibit 3.2 hereto and incorporated by reference.

 

Subsequent to the aforementioned amendments, the Company submitted all required documentation to FINRA and its transfer agent, and received final approval from FINRA regarding the name change on July 10, 2026. Due to the coincidental timing of the name change and the end of completion of the review of our quarterly financials, the Company elected to file this Form 8-K after the successful filing of its quarterly report for the three and six months ended June 30, 2026, in order to avoid any potential impacts to the timely filing of its Form 10-Q due to changes necessitated in the Edgar system. All future reports will be filed under our new name “Adia Med, Inc.”

 

Our common stock will continue to trade on the OTC Markets Venture Markets under the ticker symbol “ADIA”. Outstanding stock certificates for shares of the Company are not affected by the name change; they continue to be valid and need not be exchanged.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description of Exhibit
3.1   Certificate of Amendment
3.2   Amended and Restated Articles of Incorporation
104   Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ADIA Nutrition, Inc.
   
   
Date: August 17, 2026

By: /s/ Larry Powalisz               

Name: Larry Powalisz

Title: Chief Executive Officer

 

 

  ADIA Nutrition, Inc.
   
   
Date: August 17, 2026

By: /s/ Rebecca Miller               

Name: Rebecca Miller

Title: Chief Financial Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Name

 

Position

 

Date

         

/s/ Larry Powalisz

  Chief Executive Officer and Director   August 17, 2026
Larry Powlalisz        
         

/s/ Rebecca Miller

  Chief Financial Officer   August 17, 2026
Rebecca Miller        
         
/s/ Evan Thomas   Director   August 17, 2026
Evan Thomas        
         
/s/ Kalpesh Barot   Director   August 17, 2026
Kalpesh Barot        
         
/s/ Monica Sher   Director   August 17, 2026
Monica Sher        
         
/s/ Richard Edwards   Director   August 17, 2026
Richard Edwards        

 

 

 

 3 

 

Filing Exhibits & Attachments

5 documents